Latest press releases – plus an archive of press releases, thus recording milestones and key facts in Sunstone’s history.

Kim Stratton, CEO, resigns from Orphazyme

Orphazyme A/S (ORPHA.CO) (“Orphazyme”), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces that Kim Stratton has decided to resign from Orphazyme following a...